Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Babson Diagnostics has developed and clinically validated a proprietary capillary blood collection and analysis system that enables routine diagnostic tests using a small fingertip sample. The company has completed over 37 IRB clinical studies with more than 500,000 tests performed on over 3,000 subjects. Their COVID‑19 serology test received FDA emergency use authorization in June 2020. In recent years they have launched commercial operations for their BetterWay platform at retail pharmacies in Austin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Babson Diagnostics.